Akari Therapeutics PLC AKTX:NASDAQ

RT Quote | USD
Last | 05/13/24 EDT
1.50UNCH (UNCH)
Volume
16,426
52 week range
1.08 - 5.50
Loading...
  • Open1.55
  • Day High1.55
  • Day Low1.41
  • Prev Close1.49
  • 52 Week High5.50
  • 52 Week High Date08/07/23
  • 52 Week Low1.08
  • 52 Week Low Date04/17/24

Key Stats

  • Market Cap594,269.991
  • Shares Out396,180.00
  • 10 Day Average Volume0.04M
  • Dividend-
  • Dividend Yield-
  • Beta0.82
  • YTD % Change-51.92

KEY STATS

  • Open1.55
  • Day High1.55
  • Day Low1.41
  • Prev Close1.49
  • 52 Week High5.50
  • 52 Week High Date08/07/23
  • 52 Week Low1.08
  • 52 Week Low Date04/17/24
  • Market Cap594,269.991
  • Shares Out396,180.00
  • 10 Day Average Volume0.04M
  • Dividend-
  • Dividend Yield-
  • Beta0.82
  • YTD % Change-51.92

RATIOS/PROFITABILITY

  • EPS (TTM)-5.68
  • P/E (TTM)-0.26
  • Fwd P/E (NTM)-0.39
  • EBITDA (TTM)-16.802M
  • ROE (TTM)-1,281.64%
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Akari Therapeutics PLC

 

Profile

MORE
Akari Therapeutics, Plc is a late-stage biotechnology company. The Company is developing advanced therapies for autoimmune and inflammatory diseases. Its lead asset, investigational nomacopan, is a bispecific recombinant inhibitor of complement C5 activation and leukotriene B4 (LTB4) activity. Its pipeline includes a Phase 3 clinical trial program investigating nomacopan for pediatric hematopoietic stem cell transplant-related thrombotic microangiopathy (HSCT-TMA). It is...
Raymond Prudo-chlebosz M.D.
Non-Executive Chairman of the Board
Samir Patel M.D.
Interim President, Interim Chief Executive Officer, Director
Wendy Dicicco CPA
Interim Chief Financial Officer
Address
22 BOSTON WHARF ROAD, FL 7
Boston, MA
02210
United States

Top Peers

SYMBOLLASTCHG%CHG
GRTX
Galera Therapeutics Inc
0.1751UNCHUNCH
MNPR
Monopar Therapeutics Inc
0.651UNCHUNCH
ATHE
Alterity Therapeutics Ltd
2.10UNCHUNCH
NCNA
NuCana PLC
3.88UNCHUNCH
ONVO
Organovo Holdings Inc
0.99UNCHUNCH